Avita Medical outlines 2026 revenue target of $80M-$85M as reimbursement clarity supports multiproduct utilization
Source: SeekingAlpha
2026-02-12 20:15:14 ET
More on AVITA Medical
- AVITA Medical, Inc. (RCEL) Q4 2025 Earnings Call Transcript
- AVITA Medical, Inc. 2025 Q4 - Results - Earnings Call Presentation
- Avita Medical: Set Up For A Turnaround
- AVITA Medical GAAP EPS of -$0.38 beats by $0.02, revenue of $17.6M beats by $0.15M
- AVITA Medical Q4 2025 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
Avita Medical outlines 2026 revenue target of $80M-$85M as reimbursement clarity supports multiproduct utilization
Avita Medical Inc.
NASDAQ: RCEL
RCEL Trading
3.3% G/L:
$4.97 Last:
66,108 Volume:
$4.98 Open:
RCEL Latest News
February 23, 2026 04:15:00 pm
AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference
February 12, 2026 04:01:00 pm
AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results
RCEL Stock Data
$122,429,841
29,639,304
0.44%
22
N/A
Medical Equipment & Supplies
Healthcare
US
Valencia
